Uso de aplicativos para contagem de carboidratos como ferramenta de auxílio no autogerenciamento do diabetes mellitus tipo 1: uma revisão sistemática

• Autor(a) principal: Dantas, Natália Souza
• Data de Publicação: 2023
• Outros Autores: Albuquerque, Natasha Vasconcelos, Rebouças Moreira, Tatiana, Bezerra, Alane Nogueira, Ramos, Lorena Taúsz Tavares, Rebouças, Kamila Silva Camelo, Mendes, Renata Cristina Machado
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Research, Society and Development
• Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/39270
• topic: Diabetes mellitus type 1; Dietary carbohydrates; Wireless technology.; Diabetes mellitus tipo 1; Carboidratos da dieta; Tecnologia sem fio.; Diabetes mellitus tipo 1; Carbohidratos de la dieta; Tecnología inalámbrica.

Apps for counting carbohydrates (CCHO) contribute with countless possibilities to support the treatment of people with diabetes, helping with nutritional therapy. However, there is a scarce amount of studies that evaluate the use of this technology, making it of great value to identify its possible benefits. The present study aimed to verify the use of applications for CCHO in the self-management of the treatment of type 1 diabetes mellitus (DM1). This is a systematic review, carried out through research on the platforms MedLine, LILACS, Portal de Periódicos CAPES and EBSCOhost, with articles published from 2011 to 2021, searched between April and June 2021, with descriptors “Diabetes Mellitus, Type 1 ” and “Carbohydrate count” and “Mobile Apps”. Original studies of the randomized clinical trial type were included and non-original articles, studies carried out with pregnant women and patients with type 2 diabetes mellitus were excluded. Initially, 67 articles published in full were found, of which, after removing duplicates, 60 remained. After applying the eligibility criteria, two studies remained, with a population between 12 and 46 participants and intervention time around 90 and 104 days. The apps used were iSpy and VoiceDiab. Among the main outcomes, the improvement in CCHO accuracy, reduction in glycated hemoglobin and longer time on target stand out. Therefore, it is possible to conclude that the use of applications for the CCHO is associated with several benefits, due to its more accurate estimation of the amounts of CHO, corroborating with better glycemic control.